New Drugs, Devices Mount Assault On Diabetes

Scientists are racing to find the grail of diabetes research, a therapy that will eliminate the need for insulin injection. New products, innovative clinical trials, and a boost in federal funding all are contributing to a multifaceted effort to control one of America's most complex and dangerous ailments. With research getting promising results in several different fields, skilled people are in demand. TRANSPLANT SUCCESS: Transplantation of the whole pancreas should be performed more often, s

Written bySteve Bunk
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Scientists are racing to find the grail of diabetes research, a therapy that will eliminate the need for insulin injection. New products, innovative clinical trials, and a boost in federal funding all are contributing to a multifaceted effort to control one of America's most complex and dangerous ailments. With research getting promising results in several different fields, skilled people are in demand.


TRANSPLANT SUCCESS: Transplantation of the whole pancreas should be performed more often, surgeon David Sutherland suggests.
"The main areas where R&D appears to be having practical ramifications are in developing different medications and delivery systems," says Frank Vinicor, director of the division of diabetes at the Centers for Disease Control and Prevention in Atlanta. "Transplantation is another area."

R&D ADVANCES: New medications, delivery systems, and transplantation are all making progress in combating diabetes, says CDC's Frank Vinicor. Such R&D efforts are warranted: Diabetes is America's fourth leading cause ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies